China's Shanghai Pharmaceuticals equity investment 2018-2021, by company
In 2021, Shanghai Pharmaceutical Group Co., Ltd. invested 203.5 million yuan in Fimet Invest OY. In 2018, Shanghai Pharmaceutical Group Co., Ltd. invested almost 1.5 billion yuan in the pharmaceutical manufacturing and selling company Guangdong Tianpu Shenghua Medical. That year, Shanghai Pharmaceutical Group acquired Cardinal Health (L) Co. and Jiangsu Dazhong Pharma Logistics.